Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.56
+0.54 (2.84%)
At close: Jan 17, 2025, 4:00 PM
19.98
+0.42 (2.15%)
After-hours: Jan 17, 2025, 7:53 PM EST
Arrowhead Pharmaceuticals Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ARWR stock have an average target of 43.33, with a low estimate of 24 and a high estimate of 80. The average target predicts an increase of 121.52% from the current stock price of 19.56.
Analyst Consensus: Buy
* Price targets were last updated on Dec 20, 2024.
Analyst Ratings
The average analyst rating for ARWR stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 2 | 3 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 11 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +309.00% | Dec 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +206.75% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +309.00% | Dec 3, 2024 |
| Bernstein | Bernstein | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | +22.70% | Nov 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $62 → $45 | Buy | Maintains | $62 → $45 | +130.06% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
124.39M
from 3.55M
Increased by 3,402.96%
Revenue Next Year
278.58M
from 124.39M
Increased by 123.96%
EPS This Year
-3.35
from -5.00
EPS Next Year
-3.67
from -3.35
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 415.2M | 762.0M | 678.3M | ||
| Avg | 124.4M | 278.6M | 374.1M | ||
| Low | n/a | 111.4M | 211.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11,591.6% | 512.6% | 143.5% | ||
| Avg | 3,403.0% | 124.0% | 34.3% | ||
| Low | - | -10.4% | -24.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.04 | -2.44 | 0.54 | ||
| Avg | -3.35 | -3.67 | -2.85 | ||
| Low | -5.62 | -4.94 | -4.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.